Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/22/2003WO2003042378A1 Sulphatases and use thereof
05/22/2003WO2003042366A2 A novel saitohin gene and uses of same
05/22/2003WO2003042364A2 Identifying and controlling the growth of estrogen-responsive cells
05/22/2003WO2003042362A2 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
05/22/2003WO2003042361A2 Production of adeno-associated virus in insect cells
05/22/2003WO2003042360A2 Antisense modulation of inhibitor-kappa b-r expression
05/22/2003WO2003042359A2 Histamine receptor h3 polynucleotides
05/22/2003WO2003042358A2 Methods of using 48149, a human aminopeptidase family member
05/22/2003WO2003042357A2 Enzymes
05/22/2003WO2003042356A2 Pttg knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
05/22/2003WO2003042344A2 Apo2 ligand/trail formulations
05/22/2003WO2003042249A2 Peptide purification by means of metal ion affinity chromatography
05/22/2003WO2003042247A2 Modified anti-tnf alpha antibody
05/22/2003WO2003042246A2 Inhibitors of the notch signalling pathway for use in the treatment of cancer
05/22/2003WO2003042245A2 Growth hormone variations in humans and their uses
05/22/2003WO2003042244A2 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003WO2003042242A1 Zinc-finger protein interacting with the mch receptor
05/22/2003WO2003042240A2 Polypeptides of pseudomonas aeruginosa
05/22/2003WO2003042226A2 Single nucleotide polymorphisms in gh-1
05/22/2003WO2003041830A2 Macroporous gel, its preparation and its use
05/22/2003WO2003041734A1 Salmonella vaccine
05/22/2003WO2003041657A2 Antisense modulation of vitamin d nuclear receptor expression
05/22/2003WO2003041652A2 Method of using 18080, a human serine carboxypeptidase family member
05/22/2003WO2003041496A1 Transgenic animal
05/22/2003WO2003041493A1 Production of recombinant antibodies by means of fusion with elastin-like peptides
05/22/2003WO2003041491A2 Doubled haploid production and genetic transformation
05/22/2003WO2003041490A2 Novel isoamylases and associated methods and products
05/22/2003WO2003031631A8 Modification of plant responses to salt
05/22/2003WO2003027317A3 Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances
05/22/2003WO2003025145A3 Nanomachine compositions and methods of use
05/22/2003WO2003020763A3 Soluble t cell receptor
05/22/2003WO2003018818A8 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
05/22/2003WO2003016464A3 Cancer specific oligosaccharide sequences and use thereof
05/22/2003WO2003014297A3 Compositions and methods relating to the daptomycin biosynthetic gene cluster
05/22/2003WO2003012089A3 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
05/22/2003WO2003008554A3 Methods and compositions for cell therapy
05/22/2003WO2003006653A8 Mycoplasma spp. a39
05/22/2003WO2003004652A3 Use of a tyrosine recombinase for genetic engineering
05/22/2003WO2003000879A3 Novel promoters inducible by dna damaging conditions or agents and uses thereof
05/22/2003WO2003000874A3 Regulation of human serine/threonine protein kinase nek3
05/22/2003WO2002102987A3 Methods and compositions based on protein interactions with mastermind
05/22/2003WO2002102836A3 Moraxella (branhamella) catarrhalis antigens
05/22/2003WO2002097116A3 Delivery system for nucleic acids
05/22/2003WO2002097103A3 Constitutive plant promotor
05/22/2003WO2002090550A3 Method for preparing recombinant poxvirus
05/22/2003WO2002090533A3 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
05/22/2003WO2002085298A3 Method for detecting breast cancer cells
05/22/2003WO2002083839A3 P450 single nucleotide polymorphism biochip analysis
05/22/2003WO2002081625A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
05/22/2003WO2002079756A3 Novel molecules of the multi-drug and toxin efflux (mate) protein family and uses thereof
05/22/2003WO2002079436A3 Modulators of leukocyte activation, compositions and methods of use
05/22/2003WO2002078766A3 Combination therapy
05/22/2003WO2002073212A3 Diagnostic screens for alzheimer's disease
05/22/2003WO2002072754A3 Mva expressing modified hiv envelope, gag, and pol genes
05/22/2003WO2002072036A3 Compositions and methods comprising west nile virus polypeptides
05/22/2003WO2002070745A3 Polymorphisms in the zf9 gene linked to a predisposition for the development of inappropriate scarring of fibrosis
05/22/2003WO2002068685A3 Diagnostic test for the detection of chromosomal abnormalities in a fetus
05/22/2003WO2002068653A3 Tri-hybrid melanoma antigen
05/22/2003WO2002068466A3 Hypoxia-regulated genes
05/22/2003WO2002066637A3 Method for collecting and using nuclear mrna
05/22/2003WO2002061062A3 Human protein kinase n-like polypeptide and uses thereof
05/22/2003WO2002057487A3 Suppression of non-specific nucleic acid amplification
05/22/2003WO2002057438A3 Transgenic mice containing disruptions of the lxrb retinoid x receptor interacting protein gene
05/22/2003WO2002055687A3 Transgenic mice containing target gene disruptions
05/22/2003WO2002053740A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/22/2003WO2002051430A3 Methods of modulating toll-related receptor (trr) signaling
05/22/2003WO2002050283A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/22/2003WO2002046754A3 Functional proteomics using double phage display screening
05/22/2003WO2002044722A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
05/22/2003WO2002044427A9 Cell based triple readout assay systems for identifying compounds that effect transcription
05/22/2003WO2002040690A3 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways
05/22/2003WO2002036780A3 Stearoyl-coa desaturase gene promoter
05/22/2003WO2002036629A3 Regulation of human serotonin receptor precursor
05/22/2003WO2002033059A3 Gnk interacting amino acid decarboxylase and methods of use thereof
05/22/2003WO2002030561A3 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
05/22/2003WO2002029050A3 Regulation of human secretin receptor-like gpcr
05/22/2003WO2002026780A3 Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
05/22/2003WO2002024743A3 55063, a human nmda family member and uses thereof
05/22/2003WO2002023202A3 Method to identify antibody targets based on mass spectrometry (maldi-tof)
05/22/2003WO2002022807A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof
05/22/2003WO2002022776A9 Human coagulation factor vii variants
05/22/2003WO2002018617A3 Carotenoid production by recombinant, c1-metabolizing methanothropic bacteria
05/22/2003WO2002010389A3 Human ion channel proteins and polynucleotides encoding the same
05/22/2003WO2001086003A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung
05/22/2003WO2001079539A9 Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep
05/22/2003WO2001072774A3 Cell cycle progression proteins
05/22/2003WO2001070941A9 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
05/22/2003WO2001068708A9 Human and humanized fap-alpha-specific antibodies
05/22/2003WO2001015736A3 Interferon-beta conjugates
05/22/2003US20030097692 Plants with imidazolinone-resistant ALS
05/22/2003US20030097690 For regulating expression of heterologous nucleotide sequences in a plant
05/22/2003US20030097689 Seed-preferred promoters from end genes
05/22/2003US20030097688 Starch synthase isoform V
05/22/2003US20030097687 Herbicide tolerant phenotype with an agronomic performance, genetic stability and adaptability to different genetic backgrounds equivalent to the non-transformed cotton line in the absence of weed pressure
05/22/2003US20030097686 Growing a transgenic predominantly unsaturated temperate zone oilseed crop plant species to seed, wherein plant comprises a recombinant DNA construct integrated into the genome of its cells, harvesting a plant seed having a modified fatty acid
05/22/2003US20030097685 Lipid metabolism regulators in plants
05/22/2003US20030097683 For transformation of a host organism with a foreign RNA
05/22/2003US20030097682 Genetically modified plants with enhanced resistance to fungal diseases and a method of production thereof
05/22/2003US20030097681 Plant is cultivated in an environment contaminated with the hazardous chemical substances for decomposing and removing hazardous chemical substances
05/22/2003US20030097680 Transgenic plant
1 ... 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 ... 4023